Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1238297.RAxuGLyG1RmIOUQWhpcw4hD0YdJ4JNZ6w1PZufe_NsTeg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1238297.RAxuGLyG1RmIOUQWhpcw4hD0YdJ4JNZ6w1PZufe_NsTeg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1238297.RAxuGLyG1RmIOUQWhpcw4hD0YdJ4JNZ6w1PZufe_NsTeg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1238297.RAxuGLyG1RmIOUQWhpcw4hD0YdJ4JNZ6w1PZufe_NsTeg130_provenance.
- NP1238297.RAxuGLyG1RmIOUQWhpcw4hD0YdJ4JNZ6w1PZufe_NsTeg130_assertion description "[Downregulation of osteopontin enhances the sensitivity of glioma U251 cells to temozolomide and cisplatin by targeting the NF-?B/Bcl?2 pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238297.RAxuGLyG1RmIOUQWhpcw4hD0YdJ4JNZ6w1PZufe_NsTeg130_provenance.
- NP1238297.RAxuGLyG1RmIOUQWhpcw4hD0YdJ4JNZ6w1PZufe_NsTeg130_assertion evidence source_evidence_literature NP1238297.RAxuGLyG1RmIOUQWhpcw4hD0YdJ4JNZ6w1PZufe_NsTeg130_provenance.
- NP1238297.RAxuGLyG1RmIOUQWhpcw4hD0YdJ4JNZ6w1PZufe_NsTeg130_assertion SIO_000772 25405848 NP1238297.RAxuGLyG1RmIOUQWhpcw4hD0YdJ4JNZ6w1PZufe_NsTeg130_provenance.
- NP1238297.RAxuGLyG1RmIOUQWhpcw4hD0YdJ4JNZ6w1PZufe_NsTeg130_assertion wasDerivedFrom befree-2016 NP1238297.RAxuGLyG1RmIOUQWhpcw4hD0YdJ4JNZ6w1PZufe_NsTeg130_provenance.
- NP1238297.RAxuGLyG1RmIOUQWhpcw4hD0YdJ4JNZ6w1PZufe_NsTeg130_assertion wasGeneratedBy ECO_0000203 NP1238297.RAxuGLyG1RmIOUQWhpcw4hD0YdJ4JNZ6w1PZufe_NsTeg130_provenance.
- befree-2016 importedOn "2016-02-19" NP1238297.RAxuGLyG1RmIOUQWhpcw4hD0YdJ4JNZ6w1PZufe_NsTeg130_provenance.